Status:
COMPLETED
Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis
Lead Sponsor:
Instituto Palacios
Collaborating Sponsors:
Gynea Laboratorios SA
Conditions:
Candidiasis, Vulvovaginal
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.
Eligibility Criteria
Inclusion
- Sexually active women between 18 and 50 years
- Patients attending to the gynecologist with acute vulvovaginal candidiasis.
- Patients requiring standard treatment with clotrimazole 500 single dose and that the decision to prescribe this treatment is prior to inclusion in the study.
- Women who agree to participate in the study and has signed the informed consent sheet.
Exclusion
- Use of any medication that may interfere significantly with study assessments.
- Pregnant or breastfeeding
- Women with signs of other genital infection
- Within 3 months after childbirth or abortion
- Patients that is expected not to attend follow-up visits
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT02248506
Start Date
June 1 2013
End Date
March 1 2015
Last Update
March 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Palacios
Madrid, Madrid, Spain, 28009